Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1835 News Items found Q&A Preventing Nausea and Vomiting after Cancer Treatment: 7 Questions with an MSK Expert Monday, July 31, 2017 Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer. In the Lab Giving Drugs Together — Rather than in Sequence — May Be Key to Halting Tumor Resistance Thursday, July 27, 2017 Scientists are learning how tumors develop resistance to drugs — and what can be done about it. In the Lab Stem Cell Research Identifies Potential Drugs for Treating Zika Infection Thursday, July 20, 2017 Researchers from MSK and Weill Cornell have found that two compounds appear to fight off infection with the Zika virus. Feature Beyond the Surface: MSK’s Dental Service Aims to Make People Whole Again Wednesday, July 12, 2017 A vital part of MSK's mission is to get patients back to feeling like themselves. In the Lab When Loss Is a Gain: New Tumor Suppressor Gene Identified in Follicular Lymphoma Monday, July 3, 2017 The reason certain patients with follicular lymphoma do worse than others may come down to a missing gene. In the Lab Bacteria versus Bacteria: Two Studies Uncover Species of Microbes That Protect against Infections in People with Cancer Tuesday, June 20, 2017 Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria. Science Byte It Takes Two: A Pair of Proteins Coordinate to Direct Development of Embryonic Cells Friday, June 16, 2017 MSK researchers shed light on the signals that determine the fate of embryonic cells. In the Clinic The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers Friday, June 9, 2017 A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality. Finding Definitive Study Shows That People with Melanoma Do Not Need Immediate Lymph Node Removal Thursday, June 8, 2017 The results of a large, international randomized trial herald a change in medical practice for the treatment of melanoma. In the News #ASCO17: Post-Conference Roundup of Themes and Trends Wednesday, June 7, 2017 Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment